Type 1 diabetes

Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia

Cardiovasc DiabetolPublished Retrospective cohort study

Authors' conclusion

Peripheral artery disease in the whole cohort, and heart failure in elder subjects are the most frequent first-ever CVD events in T1D in our region. These findings deserve to be taken into account when considering primary prevention measures and when estimating CV risk in people with T1D.

Study context

Population
Patients with T1D >30 years without cardiovascular disease (CVD) before 2010, SIDIAP database, Catalonia (Spain)
Participants
8,412 patients
Exposure
Women vs Men
Outcome
First-ever CV event, type of CV event and associations with baseline characteristics
Follow-up
Up to end of 2016
Methodological detailspopulation-based
  • Population-based

Main finding

As reported in the abstract

First CV event

Patients with a first CV event

884

Incidence rate

1.62 per 100 persons-years

Peripheral vascular disease, most frequent first event

39.5%

Observational data: associations, not effects.

Further findings

Heart failure as first CV event, by sex

Baseline factors associated with first CV event

HR (95% CI)
Decreased glomerular filtration rate5.42 (4.32–6.80)
Elevated albumin/creatinine ratio3.39 (2.47–4.66)
Microvascular complications3.27 (2.85–3.75)
Hypertension3.21 (2.80–3.67)
Heart failure as first CV event, by sex — In women >65 years, HF was the most frequent event
40.5%

Baseline factors associated with first CV event

HbA1c >7.0% associated with incident CVD only in patients aged <55/60 years

Original publication

Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia. Cardiovasc Diabetol. Published 14 July 2023. doi:10.1186/s12933-023-01917-1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.